The Effects of Prior Authorization Policies on Medicaid-Enrolled Children's Use of Antipsychotic Medications: Evidence from Two Mid-Atlantic States

Special Section on Implications of CATIE: Who Are the New Users of Antipsychotic Medications?

(2014) Marisa Elena Domino et al.   PSYCHIATRIC SERVICES

Evidence-Based Use of Second-Generation Antipsychotics in a State Medicaid Pediatric Population, 2001–2005

(2014) Prathamesh Pathak et al.   PSYCHIATRIC SERVICES

National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics

(2012) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

The Relationship between Mental Health Diagnosis and Treatment with Second-Generation Antipsychotics over Time: A National Study of U.S. Medicaid-Enrolled Children

(2012) Meredith Matone et al.   HEALTH SERVICES RESEARCH

Monitoring Psychiatric Medications in Children

(2012) Robert J. Hilt   PEDIATRIC ANNALS

Economic Grand Rounds: Economic Costs of Failure to Monitor Adverse Effects of Second-Generation Antipsychotics: An Underestimated Factor

(2012) Jeanette M. Jerrell et al.   PSYCHIATRIC SERVICES

Conflicting Data on Psychotropic Use by Children

(2012) David Rubin   JAMA Pediatrics

The Partnership Access Line

(2012) Robert J. Hilt et al.   JAMA Pediatrics

Medicaid Cost Control Measures Aimed At Second-Generation Antipsychotics Led To Less Use Of All Antipsychotics

(2011) William B. Vogt et al.   HEALTH AFFAIRS

Early Diagnoses and Psychotherapeutic Medication Treatment Experiences of a Cohort of Children Under 6 Years Old Who Received Antipsychotic Treatment in Florida's Medicaid Program

(2011) Robert J. Constantine et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Trends in Antipsychotic Drug Use by Very Young, Privately Insured Children

(2011) Mark Olfson et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Assessment of Changes in Utilization of Health-Care Services after Implementation of a Prior Authorization Policy for Atypical Antipsychotic Agents

(2010) Amy Walthour et al.   ANNALS OF PHARMACOTHERAPY

Economic Impact of Prior Authorization Policies for Atypical Antipsychotics in the Treatment of Schizophrenia

(2010) Safiya Abouzaid et al.   Population Health Management

Prior Authorization for Antidepressants in Medicaid

(2009) Alyce S. Adams et al.   ARCHIVES OF INTERNAL MEDICINE

Beyond Parity: Primary Care Physicians’ Perspectives On Access To Mental Health Care

(2009) Peter J. Cunningham   HEALTH AFFAIRS

Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges

(2009) Stephen Crystal et al.   HEALTH AFFAIRS

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antipsychotics and Diabetes: An Age-Related Association

(2008) Ariel Hammerman et al.   ANNALS OF PHARMACOTHERAPY

Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents

(2008) Roger S. McIntyre et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications

(2008) J FARLEY et al.   CLINICAL THERAPEUTICS

Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change

(2008) Stephen B. Soumerai et al.   HEALTH AFFAIRS

Psychotropic Medication Patterns Among Youth in Foster Care

(2008) J. M. Zito et al.   PEDIATRICS

Effect of Prior Authorization of Second-Generation Antipsychotic Agents on Pharmacy Utilization and Reimbursements

(2008) M. R. Law et al.   PSYCHIATRIC SERVICES

Changing Trends in Pediatric Antipsychotic Use in Florida's Medicaid Program

(2008) R. Constantine et al.   PSYCHIATRIC SERVICES

A three-country comparison of psychotropic medication prevalence in youth

(2008) Julie M Zito et al.   Child and Adolescent Psychiatry and Mental Health